Tauriga Sciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TAUG research report →
Price Chart
About the company
Tauriga Sciences, Inc. (TAUG) is primarily engaged in the manufacturing and distribution of its cannabidiol (CBD) infused chewing gum, sold under the brand name Tauri-Gum. The company also offers a diverse product portfolio, which includes a line of anti-nausea solutions.
- CEO
- Seth M. Shaw
- IPO
- 2002
- Employees
- 2
- HQ
- Wappingers Falls, NY, US
Get TickerSpark's AI analysis on TAUG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.00K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.01
- P/B
- 0.00
- EV/EBITDA
- -0.21
- Div Yield
- 0.00%
- Gross Margin
- 43.00%
- Op Margin
- -1187.96%
- Net Margin
- -1271.01%
- ROE
- -753.12%
- ROIC
- -184.15%
Latest fiscal year · YoY change
- Revenue
- $285.32K+21.7%
- Gross Profit
- $122.69K+229.7%
- Op Income
- $-3,389,474
- Net Income
- $-3,626,446-19.6%
- EPS
- $-0.02+49.8%
- OCF Growth
- -69.1%
- FCF Growth
- -69.9%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.73
- RSI (14)
- 0
- Avg Volume
- 79
No earnings-call transcripts are available for TAUG yet.
- Free Float
- 97.8%
- Shares Outstanding
- 299.91M
- Float Shares
- 293.33M
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 27, 21 | SHAW SETH M | buy | 250,000 |
| Apr 1, 21 | Rosati James V | other | 0 |
| Apr 1, 21 | Sferruzzo Chris | other | 0 |
| Jul 10, 20 | SHAW SETH M | buy | 700,000 |
| Oct 6, 17 | SHAW SETH M | buy | 110,000,000 |
| Jul 5, 17 | Lacey Kevin Patrick | other | 0 |
| Jul 5, 17 | Lacey Kevin Patrick | other | 0 |
| Jun 21, 17 | SHAW SETH M | buy | 44,000,000 |
| Jun 15, 17 | SHAW SETH M | buy | 76,000,000 |
| Sep 14, 16 | Graham Thomas James | sell | 600,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TAUG coverage
Recent articles, reports, and earnings notes.
No research on TAUG yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TAUG report →Contrasting Establishment Labs (NASDAQ:ESTA) and Tauriga Sciences (OTCMKTS:TAUG)
defenseworld.net · Jan 7
Head to Head Comparison: Tauriga Sciences (OTCMKTS:TAUG) & Teladoc Health (NYSE:TDOC)
defenseworld.net · Jan 4
Premier (NASDAQ:PINC) versus Tauriga Sciences (OTCMKTS:TAUG) Head-To-Head Survey
defenseworld.net · Dec 15
Tauriga Sciences Inc. Chief Executive Officer Completes 1,500,000 Share Insider Purchase
globenewswire.com · May 9
Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order
globenewswire.com · Mar 25
Tauriga Sciences Inc. Invited to Participate in the Upcoming Kroger “Merchandising Planogram and Sales Planning” Event
globenewswire.com · Mar 10
Tauriga Sciences Inc. Receives its 9,000th E-Commerce Order
globenewswire.com · Jan 21
Tauriga Sciences Inc. Generates Record Quarterly Net Revenue, from Both Amazon and E-Commerce Business Segment
globenewswire.com · Jan 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.